High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey

Grignaschi, S; Kim, M; Zanframundo, G; Ravichandran, N; Lilleker, JB; Sen, P; Joshi, M; Agarwal, V; Kardes, S; Day, J; Makol, A; Milchert, M; Gheita, T; Salim, B; Velikova, T; Gracia-Ramos, AE; Parodis, I; Nikiphorou, E; Chatterjee, T; Tan, AL; Saavedra, MA; Shinjo, SK; Ziade, N; Knitza, J; Kuwana, M; Nune, A; Distler, O; Chinoy, H; Cavagna, L; Agarwal, V; Aggarwal, R; Gupta, L

Author(s): Grignaschi, S; Kim, M; Zanframundo, G; Ravichandran, N; Lilleker, JB; Sen, P; Joshi, M; Agarwal, V; Kardes, S; Day, J; Makol, A; Milchert, M; Gheita, T; Salim, B; Velikova, T; Gracia-Ramos, AE; Parodis, I; Nikiphorou, E; Chatterjee, T; Tan, AL; Saavedra, MA; Shinjo, SK; Ziade, N; Knitza, J; Kuwana, M; Nune, A; Distler, O; Chinoy, H; Cavagna, L; Agarwal, V; Aggarwal, R; Gupta, L;
Details: Publication Year 2023-06-14,Volume 43,Issue #9,Page 1637-1649
Journal Title: Rheumatology International
Abstract: Idiopathic inflammatory myopathies (IIMs) confer a significant risk of disability and poor quality of life, though fatigue, an important contributing factor, remains under-reported in these individuals. We aimed to compare and analyze differences in visual analog scale (VAS) scores (0-10 cm) for fatigue (VAS-F) in patients with IIMs, non-IIM systemic autoimmune diseases (SAIDs), and healthy controls (HCs). We performed a cross-sectional analysis of the data from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) international patient self-reported e-survey. The COVAD survey was circulated from December 2020 to August 2021, and details including demographics, COVID-19 history, vaccination details, SAID details, global health, and functional status were collected from adult patients having received at least one COVID-19 vaccine dose. Fatigue experienced 1 week prior to survey completion was assessed using a single-item 10 cm VAS. Determinants of fatigue were analyzed in regression models. Six thousand nine hundred and eighty-eight respondents (mean age 43.8 years, 72% female; 55% White) were included in the analysis. The overall VAS-F score was 3 (IQR 1-6). Patients with IIMs had similar fatigue scores (5, IQR 3-7) to non-IIM SAIDs [5 (IQR 2-7)], but higher compared to HCs (2, IQR 1-5; P < 0.001), regardless of disease activity. In adjusted analysis, higher VAS-F scores were seen in females (reference female; coefficient -0.17; 95%CI -0.21 to -13; P < 0.001) and Caucasians (reference Caucasians; coefficient -0.22; 95%CI -0.30 to -0.14; P < 0.001 for Asians and coefficient -0.08; 95%CI -0.13 to 0.30; P = 0.003 for Hispanics) in our cohort. Our study found that patients with IIMs exhibit considerable fatigue, similar to other SAIDs and higher than healthy individuals. Women and Caucasians experience greater fatigue scores, allowing identification of stratified groups for optimized multidisciplinary care and improve outcomes such as quality of life.
Publisher: Springer Link
Keywords: Autoimmune diseases; Covid-19; Fatigue; Myositis; Surveys and questionnaires
Research Division(s): Infectious Diseases And Immune Defence
PubMed ID: 37314497
Publisher's Version: https://doi.org/10.1007/s00296-023-05344-z
Open Access at Publisher's Site: https://doi.org/10.1007/s00296-023-05344-z
Terms of Use/Rights Notice: Refer to copyright notice on published article.
Documents: s00296-023-05344-z.pdf - (0.68MB, application/pdf)

Creation Date: 2023-06-30 02:16:05

Last Modified: 2023-07-21 09:55:05